TrialPloS one2022
No association between APOE genotype and lipid lowering with cognitive function in a randomized controlled trial of evolocumab.
Laura E Korthauer et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this paperpooled itcites it